“The quality of life for half of all men between the ages of 51 and 60, and more than 90 percent of men over age 80, has been negatively impacted by the symptoms of BPH,” said Bob Paulson, president and CEO of NxThera. “For men who don’t want to or cannot commit to life-long medical therapies or undergoing more invasive procedures to treat their BPH, our Rezūm System offers a safe, effective and durable BPH treatment option that preserves sexual function.”
For more information about Rezūm, talk with your urologist or use the physician locator at Rezūm.com to find a Rezūm-trained urologist near you. Urologists who are interested in the Rezūm System can learn more here.
Ad Statistics
Times Displayed: 112999
Times Visited: 6736 MIT labs, experts in Multi-Vendor component level repair of: MRI Coils, RF amplifiers, Gradient Amplifiers Contrast Media Injectors. System repairs, sub-assembly repairs, component level repairs, refurbish/calibrate. info@mitlabsusa.com/+1 (305) 470-8013
About NxThera
NxThera pioneered its patented Convective Water Vapor Energy (WAVE)® technology platform to treat a variety of endourological conditions. The Rezūm System to treat BPH is NxThera’s first FDA-cleared and CE-Marked indication. The Rezūm System uses radiofrequency power to create thermal energy in the form of sterile water vapor, or steam, to convectively deliver targeted, precise treatments to ablate prostate tissue in a minimally invasive transurethral procedure with minimal discomfort, and demonstrated improvements in LUTS symptoms, urine flow, quality-of-life, and preserved sexual function. The Company is conducting advanced development and clinical research to potentially expand application of its Convective WAVE technology to include the targeted treatment of cancerous prostate tissue and kidney tumors. Founded in 2008, NxThera is located in Maple Grove, Minnesota.
Back to HCB News
